Hinge Health $HNGE

Health Care · NYSE

$105.78
-2.32 (-2.15%)
As of Nov 20, 2026, 4:05 PM EST · cached
Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 25, 2026, the first target we tracked for HNGE.

Hinge Health (HNGE) is trading down at $105.78 (-2.15%) on NYSE, as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.

IPO: May 22, 2025 · $32.00 offering · NYSE

Analyst price targets on HNGE

Current price targets from 3 firms average $132, median $132, ranging from $130 to $134 — the average is 25% above the current $106. Each is tracked to its date and scored the same way a member's call is.

3 targets, newest first. Open a row for its source and scoring.

DateNov 3, 2026 FirmCanaccord Genuity RatingBuy · raises Targetat $118 · $134 +13% Horizonby Nov 2027 StatusOpen

Entry price $118, the close nearest Nov 3, 2026, when the target was reported; the target is +13% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.

Scoring Open: judged on the close on Nov 3, 2027.

Source Canaccord raises Hinge Health stock price target on strong billings Investing.com · Nov 3, 2026 · opens the publisher's site
Canaccord raised its price target on Hinge Health Inc (NYSE:HNGE) to $134 from $105
DateNov 3, 2026 FirmWells Fargo RatingOverweight · raises Targetat $117 · $132 +13% Horizonby Nov 2027 StatusOpen

Entry price $117, the close nearest Nov 3, 2026, when the target was reported; the target is +13% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Nov 2027.

Scoring Open: judged on the close on Nov 3, 2027.

Source Wells Fargo raises Hinge Health stock price target on yield strength Investing.com · Nov 3, 2026 · opens the publisher's site
Wells Fargo raised its price target on Hinge Health Inc (NYSE:HNGE) to $132 from $103, while maintaining an Overweight rating on the stock.
DateOct 25, 2026 FirmStifel RatingBuy · raises Targetat $112 · $130 +16% Horizonby Oct 2027 StatusOpen

Entry price $112, the close nearest Oct 25, 2026, when the target was reported; the target is +16% from it.

Horizon No horizon stated, so it is tracked over the 12-month default, to Oct 2027.

Scoring Open: judged on the close on Oct 25, 2027.

Source Stifel raises Hinge Health stock price target on app growth rebound Investing.com · Oct 25, 2026 · opens the publisher's site
raised its price target on Hinge Health Inc (NYSE:HNGE) to $130 from $115

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Hinge Health revenue & net income history (FY2023–FY2025)

RevenueNet incomeNet margin (right axis, %)
$587.9M$29.8M−$528.3MFY2023 revenue: $292.7MFY2023 net income: −$108.1M · Net margin −36.9%'23FY2024 revenue: $390.4MFY2024 net income: −$11.9M · Net margin −3.1%'24FY2025 revenue: $587.9MFY2025 net income: −$528.3M · Net margin −89.9%'25−89.9%−50%0%50%FY2023 net margin: −36.9%FY2024 net margin: −3.1%FY2025 net margin: −89.9%
Hinge Health annual financial statements
FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$292.7M$390.4M$587.9M
Growth (year over year)—+33.4%+50.6%
Gross profit$194.2M$299.9M$468.2M
Gross margin66.3%76.8%79.6%
Operating income−$130.5M−$31.9M−$546.4M
Operating margin−44.6%−8.2%−92.9%
Net income−$108.1M−$11.9M−$528.3M
Net margin−36.9%−3.1%−89.9%
EPS (diluted)−$8.31−$0.88−$7.77
Balance sheet
Cash and equivalents$235.0M$300.8M$208.0M
Total assets—$673.3M$744.8M
Total liabilities—$256.6M$366.2M
Shareholders' equity−$424.0M−$434.6M$178.7M
Cash flow
Operating cash flow−$63.9M$49.0M$171.4M
Capital expenditure$1.98M$1.04M$708.0K
Free cash flow−$65.9M$48.0M$170.7M
Share buybacks$0$0$65.0M

From Hinge Health's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Hinge Health in the news

Nov 12, 2026 Investing.com Hinge Health CFO James Budge sells $4.37M in stock, prices $119.52-$123.34
Nov 12, 2026 Investing.com Hinge Health exec. chairman Gabriel Mecklenburg sells $24.5 million in stock
Nov 3, 2026 Investing.com Canaccord raises Hinge Health stock price target on strong billings Target
Nov 3, 2026 Investing.com Wells Fargo raises Hinge Health stock price target on strong yield
Nov 3, 2026 Investing.com Wells Fargo raises Hinge Health stock price target on yield strength Target
Tracked from this story

Also mentions Wells Fargo

Show 1 older story
Oct 25, 2026 Investing.com Stifel raises Hinge Health stock price target on app growth rebound Target

About Hinge Health

Headquarters
San Francisco, California From SEC filings, Oct 2026

More Health Care stocks

Browse all companies →

Mentioned with Hinge Health in recent news